TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 94 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $705,000 | -5.0% | 526,454 | -19.8% | 0.00% | 0.0% |
| Q4 2018 | $742,000 | -69.6% | 656,378 | -25.8% | 0.00% | -66.7% |
| Q3 2018 | $2,441,000 | -7.3% | 884,415 | +19.9% | 0.01% | -18.2% |
| Q2 2018 | $2,634,000 | -48.8% | 737,715 | -55.9% | 0.01% | -54.2% |
| Q1 2018 | $5,140,000 | – | 1,674,341 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |